AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway.
about
Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells.Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.Association of increased primary breast tumor AGR2 with decreased disease-specific survival.
P2860
AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
AGR2 oncoprotein inhibits p38 ...... 0-mediated regulatory pathway.
@en
type
label
AGR2 oncoprotein inhibits p38 ...... 0-mediated regulatory pathway.
@en
prefLabel
AGR2 oncoprotein inhibits p38 ...... 0-mediated regulatory pathway.
@en
P2093
P2860
P50
P1433
P1476
AGR2 oncoprotein inhibits p38 ...... 0-mediated regulatory pathway.
@en
P2093
Borivoj Vojtesek
Eva Matoulkova
Eva Michalova
Pavla Bouchalova
P2860
P304
P356
10.1016/J.MOLONC.2015.12.003
P577
2015-12-17T00:00:00Z